ELEVA
Eleva develops novel biological therapies with its pharmaceutical partners. The privately-held company leverages its unique moss-based production platform to produce supreme biologics like antibodies, replacement enzymes, or fusion toxins. Eleva has successfully developed drug candidates into clinical phases.
ELEVA
Industry:
Biopharma Biotechnology Therapeutics
Founded:
1999-01-01
Address:
Freiburg, Baden-Wurttemberg, Germany
Country:
Germany
Website Url:
http://www.elevabiologics.com
Total Employee:
11+
Status:
Active
Contact:
+49 761 470 99 0
Email Addresses:
[email protected]
Total Funding:
60 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Cellestia
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Enterin
Philadelphia-based biotechnology company .
Felema
Felema provides eco-friendly biological products.
Neurimmune Holding
Neurimmune develops innovative immunotherapeutics for human diseases.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
Zukunftsfonds Heilbronn
Zukunftsfonds Heilbronn investment in Venture Round - Eleva
Official Site Inspections
http://www.elevabiologics.com Semrush global rank: 5.61 M Semrush visits lastest month: 1.51 K
- Host name: www609.your-server.de
- IP address: 162.55.254.206
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Eleva"
Eleva Biologics – Next level medicine with ease
Eleva’s team combines decades of scientific and industry experience. We relentlessly pursue those therapeutic opportunities, where our technology and expertise can make a key …See details»
Company – Eleva Biologics
Eleva is a clinical-stage biopharmaceutical company developing novel therapies and unlocking difficult-to-produce biologics based on a transformative manufacturing platform.See details»
Team – Eleva Biologics
Partnerships are at the heart of our strategy as the number of opportunities out there exceeds the capacity of one organization alone. Dr. Martin Bauer, MD, FNWC. Chief Medical Officer. profile. Dr. Andreas Busch. Chief Operations …See details»
Eleva - Crunchbase Company Profile & Funding
Eleva develops novel biological therapies with its pharmaceutical partners. The privately-held company leverages its unique moss-based production platform …See details»
Eleva And 3PBIOVIAN Sign Strategic GMP Manufacturing And …
For more information, visit www.elevabiologics.com. About 3PBIOVIAN 3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to …See details»
Eleva and 3PBIOVIAN sign strategic GMP manufacturing and …
Feb 4, 2025 https://elevabiologics.com ABOUT 3PBIOVIAN. 3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to-end …See details»
Eleva 2025 Company Profile: Valuation, Funding
Information on valuation, funding, acquisitions, investors, and executives for Eleva. Use the PitchBook Platform to explore the full profile.See details»
eleva (fka greenovation) - VentureRadar
Website: https://www.elevabiologics.com. Offers innovative therapies using moss (Bryophyta) to produce complex proteins, enabling stable engineering and reliable output for drug candidates …See details»
Eleva and 3PBIOVIAN sign strategic alliance – Eleva Biologics
Feb 4, 2025 Freiburg im Breisgau, Germany, and Pamplona-Noáin, Spain, February 04, 2025 – Eleva, a pioneer in unlocking difficult-to-produce biologics based on a breakthrough …See details»
Eleva Company Profile - Office Locations, Competitors, Revenue
Eleva has 5 employees across 2 locations and $7.03 m in total funding,. See insights on Eleva including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Eleva GmbH - CMOCRO - Domain Name
Eleva develops novel biological therapies with its pharmaceutical partners. The privately-held company leverages its unique moss-based production platform to produce supreme biologics …See details»
Eleva - Overview, News & Similar companies | ZoomInfo.com
Eleva contact info: Phone number: +49 761470990 Website: www.elevabiologics.com What does Eleva do? Based in Freiburg, Germany, Eleva develops novel biological therapies with its …See details»
Eleva Receives Orphan Drug Designation in Europe for Proprietary …
Jul 3, 2024 Eleva Receives Orphan Drug Designation in Europe for Proprietary Factor H Therapy in C3 Glomerulopathy (C3G) July 3, 2024 – BioManufacturing, Biotechnology, Clinical …See details»
Eleva Appoints Martin Bauer, MD as Chief Medical Officer Adding ...
Feb 20, 2025 Freiburg im Breisgau, Germany, February 20, 2025 – Eleva, a pioneer in unlocking difficult-to-produce biologics based on a breakthrough moss-based platform, announced today …See details»
Eleva and 3PBIOVIAN sign strategic GMP manufacturing and …
Https://elevabiologics.com ABOUT 3PBIOVIAN 3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to-end services for …See details»
Eleva Enters Clinical Development of Difficult-To-Express High ...
FREIBURG, Germany, Oct. 12, 2021 /PRNewswire/ -- Eleva, a manufacturer of superior biologics, is entering clinical phases with its own drug candidates, such as immune-regulating factor H, …See details»
Eleva Enters Clinical Development of Difficult-To-Express High ...
FREIBURG, Germany, Oct. 12, 2021 /PRNewswire/ -- Eleva, a manufacturer of superior biologics, is entering clinical phases with its own drug candid...See details»
Eleva and 3PBIOVIAN Sign Strategic GMP Manufacturing and …
Visit: https://elevabiologics.com. About 3PBIOVIAN 3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to-end services for …See details»
Eleva Enters Clinical Development of Difficult-To-Express High ...
FREIBURG, Germany, Oct. 12, 2021 /PRNewswire/ -- Eleva, a manufacturer of superior biologics, is entering clinical phases with its own drug candidates, such as immune-regulating factor H, …See details»
News – Eleva Biologics
Feb 4, 2025 Eleva, a pioneer in unlocking difficult-to-produce biologics based on a breakthrough manufacturing platform, announced today the appointment of Dr. Elisabeth Lackner to its …See details»